文献速递静脉血栓栓塞外周动脉疾病

SARS-CoV-2 大流行高峰期间 COVID-19 患者血栓栓塞事件风险的种族差异及其对结局的影响

Racial Disparities in the Risk for Thromboembolic Events in COVID-19 Patients during the Height of the SARS-CoV-2 Pandemic and Impact on Outcomes.
PubMed 文献 · Ann Vasc Surg · 2022-05-16

BACKGROUND: The primary objective of this study is to assess the risk of thromboembolic events (TEs) in hospitalized patients with coronavirus disease 2019 (COVID-19) and study the impact of TEs on hospital course and mortality risk during the initial height of the severe acute r…

要点

  • 住院COVID-19患者中血栓栓塞事件发生率为10.5%(87/826),西班牙裔患者风险高于非西班牙裔白人(OR 2.237)。
  • 合并高血压、冠心病及慢性肢体威胁性缺血与血栓栓塞风险增加相关(P<0.05)。
  • 血栓栓塞患者住院时间更长(中位13天 vs 6天)、ICU入住率更高(63% vs 33%)、院内死亡率更高(28% vs 16%)。

核心结论

  • 在SARS-CoV-2大流行初期,住院COVID-19患者中血栓栓塞事件相对常见,西班牙裔患者血栓栓塞发生率显著升高,血栓栓塞与更长住院时间和更高院内死亡率相关,动脉血栓栓塞患者死亡率显著高于静脉血栓栓塞患者。

研究设计与样本

  • 回顾性研究,纳入2020年3月15日至2020年7月1日单中心所有年龄≥18岁的住院COVID-19成人患者,共826例。

主要发现

  • 826例住院患者中,男性占56%,平均年龄60.9岁,西班牙裔占51%、非西班牙裔黑人占25%、非西班牙裔白人占18%。
  • 87例患者共记录98次血栓栓塞事件,发生率为10.5%。
  • 高血压、冠心病和慢性肢体威胁性缺血与血栓栓塞发生率增加相关(P<0.05)。

关键数值与推荐

  • 血栓栓塞患者与非血栓栓塞患者相比:住院时间中位13天 vs 6天(P<0.001),ICU入住率63% vs 33%(P<0.001),院内死亡率28% vs 16%(P=0.006)。
  • 动脉血栓栓塞患者院内死亡率高于静脉血栓栓塞患者(37% vs 15%,P=0.027)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The primary objective of this study is to assess the risk of thromboembolic events (TEs) in hospitalized patients with coronavirus disease 2019 (COVID-19) and study the impact of TEs on hospital course and mortality risk during the initial height of the severe acute respiratory syndrome coronavirus-2 pandemic. METHODS: A retrospective review of all adult inpatients (≥ 18 years old) with COVID-19 infection at a single academic institution from March 15, 2020 to July 1, 2020 was performed. Collected data included patient demographics, comorbidities, hospital admission type, TEs, laboratory values, use of anticoagulants/antiplatelet agents, hospital length of stay, and in-hospital mortality. A logistic regression was used to estimate associations between risk factors and TEs. RESULTS: A total of 826 inpatients with COVID-19 were identified. Of these, 56% were male, average age was 60.9 years, and race/ethnicity was reported as Hispanic in 51%, non-Hispanic Black in 25%, and non-Hispanic White in 18%. A total of 98 TEs were documented in 87 patients (10.5%). Hypertension, coronary artery disease, and chronic limb threatening ischemia were associated with an increased incidence of thromboembolism (P < 0.05). Hispanic patients had higher incidence of thromboembolism compared to White non-Hispanic patients (odds ratio {[OR] confidence interval [CI]}: 2.237 [1.053, 4.754], P = 0.036). As D-dimer increased, the odds of TE increased by 5.2% (OR [CI]: 1.052 [1.027, 1.077], P < 0.001). Patients with TEs had longer hospital stay (median 13 vs. 6 days, P < 0.001), higher likelihood of intensive care unit admission (63% vs. 33%, P < 0.001), and higher in-hospital mortality (28% vs. 16%, P = 0.006). Arterial TEs were associated with higher in-hospital mortality than venous TEs (37% vs. 15%, P = 0.027). CONCLUSIONS: During the initial height of the severe acute respiratory syndrome coronavirus-2 pandemic, TEs were relatively frequent in hospitalized patients with COVID-19. Racial disparities were seen with an increased proportion of minority patients admitted with respect to percentages seen in the general population. There was also a significantly increased incidence of TEs in Hispanic patients. TEs were associated with significantly longer hospital stay and higher in-hospital mortality. Patients with arterial TEs fared worse with significantly higher mortality than those with venous events. Inconsistencies in anticoagulation management early in the pandemic may have contributed to poor outcomes and more contemporary management outcomes need to be investigated.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Nam J, D'Andrea M, O'Hara A, et al. Racial Disparities in the Risk for Thromboembolic Events in COVID-19 Patients during the Height of the SARS-CoV-2 Pandemic and Impact on Outcomes. Ann Vasc Surg. 2022. PMID: 35589032. doi:10.1016/j.avsg.2022.04.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。